| Issue Type | XXXX |
|---|---|
| Country | United States |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2032-06-01 |
| Par Value | 100000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) | 700.00 |
| Coupon | 3.2 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | 700.000 |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Johnson & Johnson corporate note has a X.X % fixed rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million EUR and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Johnson & Johnson, founded in 1886 and headquartered in New Brunswick, New Jersey, is a multinational corporation focused on healthcare products, including pharmaceuticals, medical devices, and consumer health goods. The company’s extensive portfolio includes well-known brands such as Tylenol, Band-Aid, and Neutrogena, positioning it as a leader in both consumer and medical markets.